Influenza pandemics, whether mild, moderate or severe, affect a large proportion of the population and require a multisectoral response over several months or even years. For this reason, countries develop plans describing their strategies for responding to a pandemic supported by operational plans at national and subnational levels.
Seasonal influenza is a vaccine-preventable disease that each year infects approximately 10 to 30 % of Europe's population, and causes hundreds of thousands of hospitalisations across Europe. Vaccination is the most effective form of influenza prevention. Apart from vaccination and antiviral treatment the public health management includes personal protective measures.
EU case definition for diarrhoea and haemolytic uremic syndrome (HUS) caused by the epidemic strain Shiga toxin 2-producing Escherichia Coli (STEC) O104:H4
Public health advice on prevention of diarrhoeal illness with special focus on Shiga toxin - producing Escherichia coli (STEC), also called verotoxin - producing E. coli (VTEC) or enterohaemorrhagic E. coli (EHEC)
Outbreak of Shiga toxin - producing Escherichia coli (STEC), also called verotoxin-producing E. coli (VTEC) or enterohaemorrhagic E. coli (EHEC) in 2011
In EU, only 1 in every 3 MDR TB patients has a successful treatment outcome; more than half either die, fail treatment or default (stop taking treatment). XDR TB has even worse treatment outcomes: only 1 in 4 patients finishes treatment successfully.